Opendata, web and dolomites

MABIOS SIGNED

The first microalgae platform for the production of anticancer biopharmaceuticals

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MABIOS project word cloud

Explore the words cloud of the MABIOS project. It provides you a very rough idea of what is the project "MABIOS" about.

patient    obstacles    oncologic    business    patients    enter    biorefinery    unmet    expensive    treatment    revolutionize    rate    line    living    ease    treatments    opportunity    peptides    first    utilize    clear    active    purification    manufacture    small    showcase    dutch    demand    advantages    consuming    investor    micro    recombinant    genetically    agents    biorefineries    cancer    overview    solid    requiring    therapeutic    scalable    world    drastic    lines    biomanufacturing    starting    organisms    manufacturing    utilizing    risked    companies    lower    cultivation    difficult    works    anticancer    de    proof    formulate    tumours    affordable    start    proteins    biopharmaceuticals    cell    price    create    biopharmaceutical    time    regulatory    mabios    algae    meet    paclitaxel    photosynthetic    yield    urgent    market    platform    pharmaceutical    molecules    roadmap    sold    frontrunner    drugs    microalgae    limited    ingredients    engineered    yields    plan    mission   

Project "MABIOS" data sheet

The following table provides information about the project.

Coordinator
MICROALGAE WORKS BV 

Organization address
address: BARGELAAN 200
city: LEIDEN
postcode: 2333 CW
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROALGAE WORKS BV NL (LEIDEN) coordinator 50˙000.00

Map

 Project objective

Manufacturing costs remain one of the major obstacles to providing effective treatment of cancer patients. Anticancer agents are often complex biopharmaceuticals that are expensive to manufacture, requiring use of living cell lines with difficult-to-control production processes, limited yields and time-consuming purification steps. There is an urgent unmet need for an improved manufacturing process of biopharmaceuticals, to meet the high demand and lower the price of oncologic treatments. We will revolutionize the way biopharmaceuticals are produced by developing a microalgae based biorefinery platform. These biorefineries will utilize genetically engineered microalgae to efficiently produce pharmaceutical agents. Microalgae are photosynthetic micro-organisms that have unique advantages as biopharmaceutical production systems, including high growth rate, ease of cultivation and low growth costs, enabling cost effective and scalable yield of active ingredients. These will be recombinant proteins, small molecules or therapeutic peptides, starting with Paclitaxel as showcase, one of the world’s best sold anticancer drugs used as the first line treatment of a several solid tumours. Our platform has the potential to become the new manufacturing method of choice for production of highly needed biopharmaceuticals. Microalgae Works is an ambitious Dutch start-up with the mission to make anticancer treatment affordable for every patient through a drastic reduction of manufacturing costs. We are supported by leading companies in the field of biomanufacturing. The MABIOS project will (1) create a clear overview of the market opportunity for micro-algae based production of paclitaxel, (2) develop a de-risked plan for the technical development of our platform, (3) evaluate the necessary regulatory roadmap to enter the market, and (4) formulate an investor-proof business plan. We aim to become the frontrunner in biopharmaceutical production utilizing microalgae.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MABIOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MABIOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More